{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:36:30Z","timestamp":1791005790596,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      phosphate homeostasis is mediated through complex counter regulatory feed-back balance between parathyroid hormone, FGF-23 and 1,25(OH)2D. Both parathyroid hormone and FGF-23 regulate proximal tubular phosphate excretion through signaling on sodium- phosphate cotransporters II\n                      <jats:sub>a<\/jats:sub>\n                      and II\n                      <jats:sub>c<\/jats:sub>\n                      . However, the interaction between these hormones on phosphate excretion is not clearly understood. We performed the present study to evaluate whether the existence of sufficient parathyroid hormone is necessary for full phosphaturic function of FGF-23 or not.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this case-control study, 19 patients with hypoparathyroidism and their age- and gender-matched normal population were enrolled. Serum calcium, phosphate, alkaline phosphatase,parathyroid hormone, FGF-23, 25(OH)D, 1,25(OH)2D and Fractional excretion of phosphorous were assessed and compared between the two groups, using SPSS software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean serum calcium and parathyroid hormone level was significantly lower in hypoparathyroid patients in comparison with the control group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001 and\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001, respectively). We found high serum level of phosphate and FGF-23 in hypoparathyroid patients compared to the control group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001 and\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001, respectively). However, there was no significant difference in Fractional excretion of phosphorous or 1,25OH2D level between the two groups. There was a positive correlation between serum FGF-23 and Fractional excretion of phosphorous just in the normal individuals (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.79).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although the FGF-23 is a main regulator of urinary phosphate excretion but the existence of sufficient parathyroid hormone is necessary for the full phosphaturic effect of FGF-23.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-01826-5","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T14:03:31Z","timestamp":1589292211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients"],"prefix":"10.1186","volume":"21","author":[{"given":"Forough","family":"Saki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Reza","family":"Kassaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azita","family":"Salehifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2224-7250","authenticated-orcid":false,"given":"Gholam Hossein Ranjbar","family":"Omrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"key":"1826_CR1","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1038\/ki.2011.27","volume":"79","author":"H J\u00fcppner","year":"2011","unstructured":"J\u00fcppner H. Phosphate and FGF-23. Kidney Int. 2011;79:S24\u2013S7.","journal-title":"Kidney Int"},{"issue":"9","key":"1826_CR2","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1002\/jps.22614","volume":"100","author":"K-I Miyamoto","year":"2011","unstructured":"Miyamoto K-I, Haito-Sugino S, Kuwahara S, Ohi A, Nomura K, Ito M, et al. Sodium-dependent phosphate cotransporters: lessons from gene knockout and mutation studies. J Pharm Sci. 2011;100(9):3719\u201330.","journal-title":"J Pharm Sci"},{"issue":"1","key":"1826_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1152\/physiol.00034.2008","volume":"24","author":"T Berndt","year":"2009","unstructured":"Berndt T, Kumar R. Novel mechanisms in the regulation of phosphorus homeostasis. Physiology. 2009;24(1):17\u201325.","journal-title":"Physiology."},{"issue":"7","key":"1826_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.tem.2008.06.002","volume":"19","author":"M Kuro-o","year":"2008","unstructured":"Kuro-o M. Endocrine FGFs and Klothos: emerging concepts. Trends Endocrinol Metabolism. 2008;19(7):239\u201345.","journal-title":"Trends Endocrinol Metabolism"},{"issue":"6","key":"1826_CR5","doi-asserted-by":"publisher","first-page":"F1170","DOI":"10.1152\/ajprenal.00072.2005","volume":"289","author":"TJ Berndt","year":"2005","unstructured":"Berndt TJ, Schiavi S, Kumar R. \u201cPhosphatonins\u201d and the regulation of phosphorus homeostasis. Am J Physiol-Renal Physiol. 2005;289(6):F1170\u2013F82.","journal-title":"Am J Physiol-Renal Physiol"},{"issue":"4","key":"1826_CR6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1152\/physrev.2000.80.4.1373","volume":"80","author":"H Murer","year":"2000","unstructured":"Murer H, Hernando N, Forster I. Biber Jr. proximal tubular phosphate reabsorption: molecular mechanisms. Physiol Rev. 2000;80(4):1373\u2013409.","journal-title":"Physiol Rev"},{"issue":"1","key":"1826_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/01.ASN.0000045045.47494.71","volume":"14","author":"HS Tenenhouse","year":"2003","unstructured":"Tenenhouse HS, Murer H. Disorders of renal tubular phosphate transport. J Am Soc Nephrol. 2003;14(1):240\u20137.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1826_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10157-018-1653-4","volume":"23","author":"T Fujii","year":"2019","unstructured":"Fujii T, Shiozaki Y, Segawa H, Nishiguchi S, Hanazaki A, Noguchi M, et al. Analysis of opossum kidney NaPi-IIc sodium-dependent phosphate transporter to understand pi handling in human kidney. Clin Exp Nephrol. 2019;23(3):313\u201324.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"1826_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrneph.2010.17","volume":"6","author":"EG Farrow","year":"2010","unstructured":"Farrow EG, White KE. Recent advances in renal phosphate handling. Nat Rev Nephrol. 2010;6(4):207.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"1826_CR10","doi-asserted-by":"publisher","first-page":"F285","DOI":"10.1152\/ajprenal.00508.2009","volume":"299","author":"J Marks","year":"2010","unstructured":"Marks J, Debnam ES, Unwin RJ. Phosphate homeostasis and the renal-gastrointestinal axis. Am J Physiol-Renal Physiol. 2010;299(2):F285\u2013F96.","journal-title":"Am J Physiol-Renal Physiol"},{"issue":"1","key":"1826_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10157-016-1359-4","volume":"21","author":"I Kaneko","year":"2017","unstructured":"Kaneko I, Tatsumi S, Segawa H. Miyamoto K-i. control of phosphate balance by the kidney and intestine. Clin Exp Nephrol. 2017;21(1):21\u20136.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"1826_CR12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res. 2004;19(3):429\u201335.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1826_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest. 2004;113(4):561\u20138.","journal-title":"J Clin Invest"},{"key":"1826_CR14","doi-asserted-by":"crossref","unstructured":"Fujii T, Segawa H, Hanazaki A, Nishiguchi S, Minoshima S, Ohi A et al. Role of the putative PKC phosphorylation sites of the type IIc sodium-dependent phosphate transporter in parathyroid hormone regulation. Clin Exp Nephrol. 2019;23:898\u2013907.","DOI":"10.1007\/s10157-019-01725-6"},{"issue":"11","key":"1826_CR15","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1172\/JCI32738","volume":"117","author":"EJ Weinman","year":"2007","unstructured":"Weinman EJ, Biswas RS, Peng Q, Shen L, Turner CL, Xiaofei E, et al. Parathyroid hormone inhibits renal phosphate transport by phosphorylation of serine 77 of sodium-hydrogen exchanger regulatory factor\u20131. J Clin Invest. 2007;117(11):3412\u201320.","journal-title":"J Clin Invest"},{"issue":"4","key":"1826_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/NEJMcp0803050","volume":"359","author":"D Shoback","year":"2008","unstructured":"Shoback D. Hypoparathyroidism. N Engl J Med. 2008;359(4):391\u2013403.","journal-title":"N Engl J Med"},{"issue":"10","key":"1826_CR17","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.483","volume":"26","author":"JP Bilezikian","year":"2011","unstructured":"Bilezikian JP, Khan A, Potts JT, Brandi ML, Clarke BL, Shoback D, et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011;26(10):2317\u201337.","journal-title":"J Bone Miner Res"},{"key":"1826_CR18","doi-asserted-by":"crossref","unstructured":"Pajevic PD, Wein MN, Kronenberg HM. Parathyroid hormone actions on bone and kidney. Hypoparathyroidism. Milano: Springer; 2015. p. 99\u2013109.","DOI":"10.1007\/978-88-470-5376-2_11"},{"issue":"7","key":"1826_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.4158\/EP13328.OR","volume":"20","author":"N Hadker","year":"2014","unstructured":"Hadker N, Egan J, Sanders J, Lagast H, Clarke B. Understanding the burden of illness associated with hypoparathyroidism reported among patients in the paradox study. Endocr Pract. 2014;20(7):671\u20139.","journal-title":"Endocr Pract"},{"issue":"25","key":"1826_CR20","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1056\/NEJM200012213432508","volume":"343","author":"SJ Marx","year":"2000","unstructured":"Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med. 2000;343(25):1863\u201375.","journal-title":"N Engl J Med"},{"issue":"11","key":"1826_CR21","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/jbmr.1979","volume":"28","author":"L Underbjerg","year":"2013","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res. 2013;28(11):2277\u201385.","journal-title":"J Bone Miner Res"},{"issue":"12","key":"1826_CR22","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/jbmr.2004","volume":"28","author":"J Powers","year":"2013","unstructured":"Powers J, Joy K, Ruscio A, Lagast H. Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J Bone Miner Res. 2013;28(12):2570\u20136.","journal-title":"J Bone Miner Res"},{"key":"1826_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fendo.2016.00172","volume":"7","author":"EG Abate","year":"2017","unstructured":"Abate EG, Clarke BL. Review of hypoparathyroidism. Front Endocrinol. 2017;7:172.","journal-title":"Front Endocrinol"},{"key":"1826_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1146\/annurev.physiol.69.040705.141729","volume":"69","author":"T Berndt","year":"2007","unstructured":"Berndt T, Kumar R. Phosphatonins and the regulation of phosphate homeostasis. Annu Rev Physiol. 2007;69:341\u201359.","journal-title":"Annu Rev Physiol"},{"issue":"9","key":"1826_CR25","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1681\/ASN.2005050573","volume":"16","author":"EA Imel","year":"2005","unstructured":"Imel EA, Econs MJ. Fibroblast growth factor 23: roles in health and disease. J Am Soc Nephrol. 2005;16(9):2565\u201375.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"1826_CR26","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1172\/JCI36479","volume":"118","author":"LD Quarles","year":"2008","unstructured":"Quarles LD. Endocrine functions of bone in mineral metabolism regulation. J Clin Invest. 2008;118(12):3820\u20138.","journal-title":"J Clin Invest"},{"issue":"8","key":"1826_CR27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/nep.12268","volume":"19","author":"SJ Tan","year":"2014","unstructured":"Tan SJ, Smith ER, Hewitson TD, Holt SG, Toussaint ND. The importance of klotho in phosphate metabolism and kidney disease. Nephrology. 2014;19(8):439\u201349.","journal-title":"Nephrology."},{"issue":"4","key":"1826_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/MNH.0b013e3282fd6e5b","volume":"17","author":"TM Strom","year":"2008","unstructured":"Strom TM, J\u00fcppner H. Phex, FGF23, DMP1 and beyond. Curr Opin Nephrol Hypertens. 2008;17(4):357\u201362.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"1826_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.bone.2012.05.015","volume":"51","author":"O Andrukhova","year":"2012","unstructured":"Andrukhova O, Zeitz U, Goetz R, Mohammadi M, Lanske B, Erben RG. FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1\/2\u2013SGK1 signaling pathway. Bone. 2012;51(3):621\u20138.","journal-title":"Bone."},{"issue":"5","key":"1826_CR30","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1681\/ASN.2008070783","volume":"20","author":"EG Farrow","year":"2009","unstructured":"Farrow EG, Davis SI, Summers LJ, White KE. Initial FGF23-mediated signaling occurs in the distal convoluted tubule. J Am Soc Nephrol. 2009;20(5):955\u201360.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1826_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s10157-016-1357-6","volume":"21","author":"M Kuro-o","year":"2017","unstructured":"Kuro-o M. The FGF23 and Klotho system beyond mineral metabolism. Clin Exp Nephrol. 2017;21(1):64\u20139.","journal-title":"Clin Exp Nephrol"},{"issue":"5747","key":"1826_CR32","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.1114245","volume":"310","author":"Q Chang","year":"2005","unstructured":"Chang Q, Hoefs S, Van Der Kemp A, Topala C, Bindels R, Hoenderop J. The \u00df-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science. 2005;310(5747):490\u20133.","journal-title":"Science."},{"issue":"12","key":"1826_CR33","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1210\/endo.140.12.7173","volume":"140","author":"JA Cole","year":"1999","unstructured":"Cole JA. Parathyroid hormone activates mitogen-activated protein kinase in opossum kidney cells. Endocrinology. 1999;140(12):5771\u20139.","journal-title":"Endocrinology."},{"issue":"8","key":"1826_CR34","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1681\/ASN.2008080873","volume":"20","author":"T de Groot","year":"2009","unstructured":"de Groot T, Lee K, Langeslag M, Xi Q, Jalink K, Bindels RJ, et al. Parathyroid hormone activates TRPV5 via PKA-dependent phosphorylation. J Am Soc Nephrol. 2009;20(8):1693\u2013704.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1826_CR35","doi-asserted-by":"publisher","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","volume":"299","author":"V Lavi-Moshayoff","year":"2010","unstructured":"Lavi-Moshayoff V, Wasserman G, Meir T, Silver J, Naveh-Many T. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol-Renal Physiol. 2010;299(4):F882\u2013F9.","journal-title":"Am J Physiol-Renal Physiol"},{"issue":"5831","key":"1826_CR36","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1126\/science.1135901","volume":"316","author":"A Imura","year":"2007","unstructured":"Imura A, Tsuji Y, Murata M, Maeda R, Kubota K, Iwano A, et al. \u03b1-Klotho as a regulator of calcium homeostasis. Science. 2007;316(5831):1615\u20138.","journal-title":"Science."},{"issue":"12","key":"1826_CR37","first-page":"4003","volume":"117","author":"IZ Ben-Dov","year":"2007","unstructured":"Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest. 2007;117(12):4003\u20138.","journal-title":"J Clin Invest"},{"issue":"1","key":"1826_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1677\/JOE-07-0267","volume":"195","author":"T Krajisnik","year":"2007","unstructured":"Krajisnik T, Bj\u00f6rklund P, Marsell R, Ljunggren O, Akerstr\u00f6m G, Jonsson KB, et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol. 2007;195(1):125\u201331.","journal-title":"J Endocrinol"},{"issue":"7","key":"1826_CR39","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1681\/ASN.2009040427","volume":"21","author":"R Canalejo","year":"2010","unstructured":"Canalejo R, Canalejo A, Martinez-Moreno JM, Rodriguez-Ortiz ME, Estepa JC, Mendoza FJ, et al. FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol. 2010;21(7):1125\u201335.","journal-title":"J Am Soc Nephrol"},{"key":"1826_CR40","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.mce.2016.07.035","volume":"436","author":"O Andrukhova","year":"2016","unstructured":"Andrukhova O, Streicher C, Zeitz U, Erben RG. Fgf23 and parathyroid hormone signaling interact in kidney and bone. Mol Cell Endocrinol. 2016;436:224\u201339.","journal-title":"Mol Cell Endocrinol"},{"issue":"17","key":"1826_CR41","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med. 2003;348(17):1656\u201363.","journal-title":"N Engl J Med"},{"issue":"11","key":"1826_CR42","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metabolism. 2002;87(11):4957\u201360.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"3","key":"1826_CR43","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/BF02480555","volume":"2","author":"K-I Miyamoto","year":"1998","unstructured":"Miyamoto K-I, Taketani Y, Morita K, Segawa H, Nii T, Fujioka A, et al. Molecular and cellular regulation of renal phosphate transporters in X-linked hypophosphatemia. Clin Exp Nephrol. 1998;2(3):178\u201382.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"1826_CR44","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s101570170002","volume":"5","author":"T Nii","year":"2001","unstructured":"Nii T, Taketani Y, Tani Y, Ohkido I, Segawa H, Yamamoto H, et al. Direct demonstration of humorally mediated inhibition of the transcription of phosphate transporter in XLH patients. Clin Exp Nephrol. 2001;5(3):144\u201352.","journal-title":"Clin Exp Nephrol"},{"issue":"8","key":"1826_CR45","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","volume":"143","author":"T Shimada","year":"2002","unstructured":"Shimada T, Muto T, Urakawa I, Yoneya T, Yamazaki Y, Okawa K, et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology. 2002;143(8):3179\u201382.","journal-title":"Endocrinology."},{"issue":"4","key":"1826_CR46","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1359\/jbmr.070107","volume":"22","author":"EA Imel","year":"2007","unstructured":"Imel EA, Hui SL, Ecibs MJ. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res. 2007;22(4):520\u20136.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1826_CR47","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ajhg.2010.01.010","volume":"86","author":"V Levy-Litan","year":"2010","unstructured":"Levy-Litan V, Hershkovitz E, Avizov L, Leventhal N, Bercovich D, Chalifa-Caspi V, et al. Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet. 2010;86(2):273\u20138.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"1826_CR48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ajhg.2010.01.006","volume":"86","author":"B Lorenz-Depiereux","year":"2010","unstructured":"Lorenz-Depiereux B, Schnabel D, Tiosano D, H\u00e4usler G, Strom TM. Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet. 2010;86(2):267\u201372.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1826_CR49","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 2003;112(5):683\u201392.","journal-title":"J Clin Invest"},{"issue":"11","key":"1826_CR50","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci. 2001;98(11):6500\u20135.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"1826_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28(1):1\u201330.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1826_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF02480556","volume":"2","author":"PS Rowe","year":"1998","unstructured":"Rowe PS. X-linked rickets and tumor-acquired osteomalacia: PHEX and the missing link. Clin Exp Nephrol. 1998;2(3):183\u201393.","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"1826_CR53","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1210\/jc.2004-0724","volume":"89","author":"A Gupta","year":"2004","unstructured":"Gupta A, Winer K, Econs M, Marx S, Collins M. FGF-23 is elevated by chronic hyperphosphatemia. J Clin Endocrinol Metabolism. 2004;89(9):4489\u201392.","journal-title":"J Clin Endocrinol Metabolism."},{"key":"1826_CR54","doi-asserted-by":"crossref","unstructured":"Yamashita H, Yamazaki Y, Hasegawa H, Yamashita T, Fukumoto S, Shigematsu T, Kazama JJ, Fukagawa M, Noguchi S. Fibroblast growth factor-23 (FGF23) in patients with transient hypoparathyroidism: its important role in serum phosphate regulation. Endocr J. 2007;54(3):465-70.","DOI":"10.1507\/endocrj.K06-156"},{"issue":"10","key":"1826_CR55","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1210\/en.2007-0243","volume":"148","author":"X Bai","year":"2007","unstructured":"Bai X, Miao D, Goltzman D, Karaplis AC. Early lethality in Hyp mice with targeted deletion of Pth gene. Endocrinology. 2007;148(10):4974\u201383.","journal-title":"Endocrinology."},{"issue":"1","key":"1826_CR56","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12020-016-1141-0","volume":"55","author":"BL Clarke","year":"2017","unstructured":"Clarke BL, Vokes TJ, Bilezikian JP, Shoback DM, Lagast H, Mannstadt M. Effects of parathyroid hormone rhPTH (1\u201384) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study. Endocrine. 2017;55(1):273\u201382.","journal-title":"Endocrine."},{"issue":"5","key":"1826_CR57","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.clinthera.2014.04.001","volume":"36","author":"BL Clarke","year":"2014","unstructured":"Clarke BL, Berg JK, Fox J, Cyran JA, Lagast H. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1\u201384) in patients with hypoparathyroidism: an open-label, single-dose, phase I study. Clin Ther. 2014;36(5):722\u201336.","journal-title":"Clin Ther"},{"issue":"10","key":"1826_CR58","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1002\/jbmr.470","volume":"26","author":"T Sikjaer","year":"2011","unstructured":"Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L, Group HS. The effect of adding PTH (1\u201384) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J Bone Miner Res. 2011;26(10):2358\u201370.","journal-title":"J Bone Miner Res"},{"key":"1826_CR59","doi-asserted-by":"crossref","unstructured":"Gracia-Iguacel C, Gonzalez-Parra E, Rodriguez-Osorio L, Sanz AB, Almaden Y, de la Piedra C, Egido J, Rodriguez M, Ortiz A. Correction of hypocalcemia allows optimal recruitment of FGF-23-dependent phosphaturic mechanisms in acute hyperphosphatemia post-phosphate enema. J Bone Miner Metab. 2013;31(6):703-7.","DOI":"10.1007\/s00774-013-0435-z"},{"key":"1826_CR60","doi-asserted-by":"crossref","unstructured":"Rodriguez-Ortiz ME, Lopez I, Mu\u00f1oz-Casta\u00f1eda JR, Martinez-Moreno JM, Ram\u00edrez AP, Pineda C, Canalejo A, Jaeger P, Aguilera-Tejero E, Rodriguez M, Felsenfeld A. Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol. 2012;23(7):1190-7.","DOI":"10.1681\/ASN.2011101006"},{"key":"1826_CR61","doi-asserted-by":"crossref","unstructured":"Yamashita H, Yamashita T, Miyamoto M, Shigematsu T, Kazama JJ, Shimada T, Yamazaki Y, Fukumoto S, Fukagaw M, Noguchi S. Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism. Eur J Endocrinol. 2004;151(1):55-60.","DOI":"10.1530\/eje.0.1510055"},{"key":"1826_CR62","doi-asserted-by":"crossref","unstructured":"Ramon I, Kleynen P, Body JJ, Karmali R. Fibroblast growth factor 23 and its role in phosphate homeostasis. Eur J Endocrinol. 2010;162(1):1.","DOI":"10.1530\/EJE-09-0597"},{"key":"1826_CR63","doi-asserted-by":"crossref","unstructured":"Nakanishi S, Kazama JJ, Nii-Kono T, Omori K, Yamashita T, Fukumoto S, Gejyo F, Shigematsu T, Fukagawa M. Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients. Kidney Int. 2005;67(3):1171-8.","DOI":"10.1111\/j.1523-1755.2005.00184.x"},{"key":"1826_CR64","doi-asserted-by":"crossref","unstructured":"Sato T, Tominaga Y, Ueki T, Goto N, Matsuoka S, Katayama A, Haba T, Uchida K, Nakanishi S, Kazama JJ, Gejyo F. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism. Am J Kidney Dis. 2004;44(3):481-7.","DOI":"10.1016\/S0272-6386(04)00817-0"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01826-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01826-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01826-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T19:35:14Z","timestamp":1620761714000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01826-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1826"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01826-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.12237\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12237\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"7 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Shiraz University of Medical Sciences local ethic committee and vice-chancellor of research at SUMS approved this study with number 1396-01-01-15805. All the patients signed a written informed consent form after a session explaining the aim, method and goal of the study for each participant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the patients signed a written informed consent form to publish their data in manuscript after a session explaining the aim, method and goal of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Gholamhossein Ranjbar Omrani, Azita Salehifar, Seyed Reza Kassaee and Forough Saki declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}